Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality

David P Smith, Emily Banks, Mark S Clements, Robert A Gardiner and Bruce K Armstrong
Med J Aust 2010; 192 (2): . || doi: 10.5694/j.1326-5377.2010.tb03438.x
Published online: 18 January 2010

In reply: The letter by Arnold highlights the practical dilemma facing busy doctors when communicating with patients about whether to screen for various cancers, prostate cancer in particular. There are no easy answers at present, although presentation of both sides of the argument regarding prostate cancer testing helps doctors and patients make a shared decision.1 We believe the following decision-aid show card, written in plain English, is an excellent resource to assist with this: < >.

  • David P Smith1
  • Emily Banks2
  • Mark S Clements2
  • Robert A Gardiner3,4
  • Bruce K Armstrong5

  • 1 Cancer Epidemiology Research Unit, Cancer Council NSW, Sydney, NSW.
  • 2 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
  • 3 University of Queensland Centre for Clinical Research, Brisbane, QLD.
  • 4 Royal Brisbane and Women's Hospital, Brisbane, QLD.
  • 5 School of Public Health, University of Sydney, Sydney, NSW.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.